Latest: Watch here for details of new products and services.
- About Us
- Pharmalicensing - Open Innovation for the life sciences
- Our Products
- Overview
- Partnering Search
- Company Profiling
- Partneringtools
- Reports
- Partnering Consulting
- Due Diligence
- Comparison
- Due Diligence
- Overview
- Top Applications
- Online Panel Discussions
- Request Consultation
- Case Studies
- See what others think about our service
- Newsletter
- Partnering update
- Key reports
- Subscribe
- Quick Links
- Profile now
- Register now
- Profiled companies
- Featured events
- Industry news
- PR Newswire
- Jobs
- Forums
- Contact Pharmalicensing
- Send an email
- Call us: +44 1904 520460
- Request a callback
- RSS Feeds
- Keep up to date
Pharmalicensing Ltd
is a division of
is a division of
- Companies
- Browse
Companies
Specialty pharmaceutical and drug delivery company engaged in the research and manufacture of collagen-based technologies for local drug delivery, surgical implants, advanced wound care and oncology. More
Fresenius Kabi is Europe's leading company in the field of infusion and nutrition therapies for seriously-ill and chronically-ill patients. More
Fannin is a distributor of third party and own brand pharmaceuticals/ medical devices to hospital, community and private healthcare markets. More
Alliance pharmaceuticals is a dynamic UK pharmaceutical company with a successful acquisition and partnership track record More
Based on the expertise of B. Braun, one of the world's leading healthcare providers, the OEM Division supplies system-built outsourcing solutions to the pharmaceutical industry. More
BPL is one of the leading suppliers of plasma derived products in the global fractionation industry. BPL is a not-for-profit organization wholly owned by the UK government More
Pharmaceutical sales to the UK hospital market. More
The University of Edinburgh has an international reputation for world-class research in medicine and biotechnology. More
LFB is a fully integrated pharmaceutical company exclusively dedicated to therapeutic proteins. LFB has developed a proprietary platform to create and develop highly cytotoxic MAb's More
The core technology of FAB is based on a new class of patented biopolymers obtained from chemical modifications of hyaluronan More
Your selection
Browse By
- Industry sector
- Academic/Research
- Animal health
- Biotechnology
- Diagnostic
- Drug delivery
- Drug discovery
- Medical device
- Non-profit org./Government
- Pharmaceutical
- Research tools
- Service
- Therapeutic target
- Adhesion
- Anesthesia
- Bleeding
- Cosmetic surgery
- Dialysis
- Disinfectant
- Fibrosis
- General surgery
- Infection control
- Infusion
- Injection
- Intravenous
- Irrigation
- Perfusion
- Plasma expander
- Plasma substitute
- Surgery (other)
- Tissue grafting
- Transplantation
- Wound closure
- Geographic location
- Albania
- Andorra
- Austria
- Belgium
- Belorussia
- Bosnia-Herzegovina
- Bulgaria
- Croatia
- Cyprus
- Czech Republic
- Denmark
- Estonia
- Finland
- France
- Germany
- Greece
- Greenland
- Hungary
- Iceland
- Ireland
- Italy
- Latvia
- Liechtenstein
- Lithuania
- Luxembourg
- Macedonia
- Malta
- Netherlands
- Norway
- Poland
- Portugal
- Romania
- Russia
- San Marino
- Slovakia
- Slovenia
- Spain
- Sweden
- Switzerland
- Turkey
- Ukraine
- United Kingdom
- Yugoslavia
© Copyright 1995-2008 Pharmalicensing Ltd, is a division of 
All rights reserved. Terms and Conditions | Site map | Contact us